Abstract
Cytokine response gene #6 (CR6), cloned from interleukin 2-stimulated T lymphocytes, is homologous to GADD45 and MyD118, genes which promote cell cycle arrest and apoptosis. To determine how this gene family could possibly mediate both cell survival/proliferation and cell cycle arrest/death, transfectants were generated so that the genes could be expressed ectopically, independently from their normal inducing agents. In cycling retinoblastoma protein-negative (pRb-) cells, ectopic CR6 expression blocked G2/M transition, but did not prevent G1/S transition so that endoreduplication resulted. By comparison, when CR6, GADD45, and MyD118 genes were expressed ectopically in proliferating pRb+ cells, either G1/S or G2/M transition was effectively blocked, so that there was no endoreduplication. Consistent with these findings, in proliferating pRb-cells, ectopic expression of CR6 promoted the expression of both G1 and G2/M cyclins. By comparison, in pRb+ cells, the expression of G1 cyclins was increased, while expression of the mitotic cyclins was decreased. However, in pRb+ cells, cyclin-dependent kinase activities associated with both G1 and G2/M cyclins were decreased. Moreover, ectopic expression of all three genes resulted in the expression of the CKI, p21, both in pRb− and pRb+ cells. The physiologic induction of CR6 expression by IL2 in quiescent normal human T cells occurs transiently in the first half of G1, coordinately with the expression of p21. Therefore, this gene family regulates G1 and G2, and promotes either cell growth or arrest by a common mechanism.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Abdollahi A, Lord KA, Hoffman-Liebermann B and Liebermann DA. . 1991 Oncogene 6: 165–167.
Beadling C, Johnson KW and Smith KA. . 1993 Proc. Natl. Acad. Sci. USA 90: 2719–2723.
Benito J, Martin-Castellanos C and Moreno S. . 1998 EMBO J 17: 482–497.
Cantrell DA and Smith KA. . 1984 Science 224: 1312–1316.
Correa-Bordes J, Gulli MP and Nurse P. . 1997 EMBO J 16: 4657–4664.
Correa-Bordes J and Nurse P. . 1995 Cell 83: 1001–1009.
Darzynkiewicz Z, Gong J, Juan G, Ardelt B and Traganos F. . 1996 Cytometry 25: 1–13.
Darzynkiewicz Z, Gong J and Traganos F. . 1994 Methods Cell. Biol. 41: 421–435.
Fornace Jr AJ, Alamo Jr I and Hollander MC. . 1988 Proc. Natl. Acad. Sci. USA 85: 8800–8804.
Hall PA, Kearsey JM, Coates PJ, Norman DG, Warbrick E and Cox LS. . 1995 Oncogene 10: 2427–2433.
Hollander MC, Alamo I, Jackman J, Wang MG, McBride OW and Fornace Jr AJ . 1993 J. Biol. Chem. 268: 24385–24393.
Kamijo T, Weber JD, Zambetti G, Zindy F, Roussel MF and Sherr CJ. . 1998 Proc. Natl. Acad. Sci. USA 95: 8292–8297.
Kastan MB, Zhan Q, el-Deiry WS, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B and Fornace Jr AJ. . 1992 Cell 71: 587–597.
Kearsey JM, Coates PJ, Prescott AR, Warbrick E and Hall PA. . 1995 Oncogene 11: 1675–1683.
Levine AJ. . 1997 Cell 88: 323–331.
Medema RH, Klompmaker R, Smits VA and Rijksen G. . 1998 Oncogene 16: 431–441.
Moreno S and Nurse P. . 1994 Nature 367: 236–242.
Niculescu ABR, Chen X, Smeets M, Hengst L, Prives C and Reed SI. . 1998 Mol. Cell. Biol. 18: 629–643.
Nourse J, Firpo E, Flanagan WM, Coats S, Polyak K, Lee MH, Massague J, Crabtree GR and Roberts JM. . 1994 Nature 372: 570–573.
Pomerantz J, Schreiber-Agus N, Liegeois NJ, Silverman A, Alland L, Chin L, Potes J, Chen K, Orlow I, Lee HW, Cordon-Cardo C and De Pinho RA. . 1998 Cell 92: 713–723.
Schulze A, Zerfass K, Spitkovsky D, Middendorp S, Berges J, Helin K, Jansen-Durr P and Henglein B. . 1995 Proc. Natl. Acad. Sci. USA 92: 11264–11268.
Selvakumaran M, Lin HK, Sjin RT, Reed JC, Liebermann DA and Hoffman B. . 1994 Mol. Cell. Biol. 14: 2352–2360.
Sherr CJ. . 1998 Genes Dev. 12: 2984–2991.
Smith KA. . 1988 Science 240: 1169–1176.
Smith KA. . 1995 Ann. N.Y. Acad. Sci. 766: 263–271.
Smith KA, Favata MF and Oroszlan S. . 1983 J. Immunol. 131: 1808–1815.
Smith ML, Chen IT, Zhan Q, Bae I, Chen CY, Gilmer TM, Kastan MB, O'Connor PM and Fornace Jr AJ. . 1994 Science 266: 1376–1380.
Takekawa M and Saito H. . 1998 Cell 95: 521–530.
Taniguchi T, Matsui H, Fujita T, Takaoka C, Kashima N, Yoshimoto R and Hamuro J. . 1983 Nature 302: 305–310.
Vairapandi M, Balliet AG, Fornace Jr AJ, Hoffman B and Liebermann DA. . 1996 Oncogene 12: 2579–2594.
Zhan Q, Bae I, Kastan MB and Fornace Jr AJ. . 1994a Cancer Res. 54: 2755–2760.
Zhan Q, Lord KA, Alamo Jr I, Hollander MC, Carrier F, Ron D, Kohn KW, Hoffman B, Liebermann DA and Fornace Jr AJ. . 1994b Mol. Cell. Biol. 14: 2361–2371.
Zhang Y, Xiong Y and Yarbrough WG. . 1998 Cell 92: 725–734.
Acknowledgements
We thank Charles Sherr for helpful comments, and Albert Fornace, Daniel Liebermann and Hsiou-Chi Liou for critical reading of the manuscript. This work was performed in partial fulfilment of a Doctor of Philosophy degree (W Fan) from Cornell University, Weill Graduate School of Medical Sciences. Support was derived from the National Institutes of Health, NIAID grant # RO1 AI 32031-23.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fan, W., Richter, G., Cereseto, A. et al. Cytokine response gene 6 induces p21 and regulates both cell growth and arrest. Oncogene 18, 6573–6582 (1999). https://doi.org/10.1038/sj.onc.1203054
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1203054
Keywords
This article is cited by
-
Dynamic phosphorylation of Histone Deacetylase 1 by Aurora kinases during mitosis regulates zebrafish embryos development
Scientific Reports (2016)
-
Lipopolysaccharide treatment arrests the cell cycle of BV-2 microglial cells in G1 phase and protects them from UV light-induced apoptosis
Journal of Neural Transmission (2015)
-
Crystal structure of human Gadd45 reveals an active dimer
Protein & Cell (2011)
-
Repression of Gadd45α by activated FLT3 and GM-CSF receptor mutants contributes to growth, survival and blocked differentiation
Leukemia (2009)
-
The histone deacetylase inhibitor trichostatin A induces GADD45γ expression via Oct and NF-Y binding sites
Oncogene (2008)